Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria

We report the first in vitro and genetic confirmation of Malarone(®) (GlaxoSmithKline; atovaquone and proguanil hydrochloride) resistance in Plasmodium falciparum acquired in Africa. On presenting with malaria two weeks after returning from a 4-week visit to Lagos, Nigeria without prophylaxis, a mal...

Descripción completa

Detalles Bibliográficos

Publicado en:	Malar J
Autores principales:	Fivelman, Quinton L, Butcher, Geoffrey A, Adagu, Ipemida S, Warhurst, David C, Pasvol, Geoffrey
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2002
Materias:	Case Report
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC111499/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12057021/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1475-2875-1-1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!